{
    "title": "113_s1277",
    "content": "The Act may be cited as the \"Combating Prescription Drug Abuse Act\". It establishes a commission. The Combating Prescription Drug Abuse Commission is established with 30 members appointed by the Comptroller General of the United States, in consultation with the Secretary of Health and Human Services and the Attorney General. The members include individuals from health care and law enforcement groups, such as representatives from the Drug Enforcement Administration, Food and Drug Administration, and Office of National Drug Control Policy. The Combating Prescription Drug Abuse Commission will consist of representatives from various groups including patient advocacy, pharmacy, prescribers, hospitals, public policy experts, State attorneys general, and law enforcement officials. The appointments of the members will be made within 180 days after the enactment of the Act, with the Co-Chairs being the representatives of the Drug Enforcement Administration and the Food and Drug Administration. The Commission, with Co-Chairs from the Drug Enforcement Administration and the Food and Drug Administration, will meet regularly to review federal initiatives on prescription drug abuse prevention, identify gaps in safe drug use, and report to Congress. The Commission, with Co-Chairs from the Drug Enforcement Administration and the Food and Drug Administration, will issue a report to Congress within 1 year of the enactment of this Act. The report will describe efforts to prevent drug diversion and abuse while ensuring patient access to medications, and will include specific recommendations for federal agencies. The Commission, with Co-Chairs from the Drug Enforcement Administration and the Food and Drug Administration, will issue a report to Congress within 1 year of the enactment of this Act. The report will cover topics such as prescription drug monitoring, illegal internet drug sites, proper disposal of prescription drugs, and identifying active areas of concern. The Commission will issue a report to Congress within 1 year, covering topics like prescription drug abuse, collaboration among Federal agencies, resource needs for law enforcement, education improvement, abuse-resistant products, and recommendations for reducing robberies. The Commission has the power to hold hearings, gather information from federal agencies, and keep obtained information confidential. The Commission, empowered to hold hearings and gather confidential information from federal agencies, will terminate two years after member appointment. $3,000,000 is authorized for fiscal years 2014-2016, with a limitation on using funds for Commission recommendations."
}